These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 23226580)

  • 1. SRC points the way to biomarkers and chemotherapeutic targets.
    Krishnan H; Miller WT; Goldberg GS
    Genes Cancer; 2012 May; 3(5-6):426-35. PubMed ID: 23226580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterocellular N-cadherin junctions enable nontransformed cells to inhibit the growth of adjacent transformed cells.
    Sheehan SA; Retzbach EP; Shen Y; Krishnan H; Goldberg GS
    Cell Commun Signal; 2022 Feb; 20(1):19. PubMed ID: 35177067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of cadherin mediated contact normalization on oncogenic Src kinase mediated gene expression and protein phosphorylation.
    Nicoletto RE; Holdcraft CJ; Yin AC; Retzbach EP; Sheehan SA; Greenspan AA; Laugier CM; Trama J; Zhao C; Zheng H; Goldberg GS
    Sci Rep; 2024 Oct; 14(1):23942. PubMed ID: 39397108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SRC induces podoplanin expression to promote cell migration.
    Shen Y; Chen CS; Ichikawa H; Goldberg GS
    J Biol Chem; 2010 Mar; 285(13):9649-9656. PubMed ID: 20123990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of miRNA expression by Src and contact normalization: effects on nonanchored cell growth and migration.
    Li X; Shen Y; Ichikawa H; Antes T; Goldberg GS
    Oncogene; 2009 Dec; 28(48):4272-83. PubMed ID: 19767772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SRC uses Cas to suppress Fhl1 in order to promote nonanchored growth and migration of tumor cells.
    Shen Y; Jia Z; Nagele RG; Ichikawa H; Goldberg GS
    Cancer Res; 2006 Feb; 66(3):1543-52. PubMed ID: 16452211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tyrosine phosphorylation within the SH3 domain regulates CAS subcellular localization, cell migration, and invasiveness.
    Janoštiak R; Tolde O; Brůhová Z; Novotný M; Hanks SK; Rösel D; Brábek J
    Mol Biol Cell; 2011 Nov; 22(22):4256-67. PubMed ID: 21937722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antitumor activity of saracatinib (AZD0530), a c-Src/Abl kinase inhibitor, alone or in combination with chemotherapeutic agents in gastric cancer.
    Nam HJ; Im SA; Oh DY; Elvin P; Kim HP; Yoon YK; Min A; Song SH; Han SW; Kim TY; Bang YJ
    Mol Cancer Ther; 2013 Jan; 12(1):16-26. PubMed ID: 23144237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crk-associated substrate tyrosine phosphorylation sites are critical for invasion and metastasis of SRC-transformed cells.
    Brábek J; Constancio SS; Siesser PF; Shin NY; Pozzi A; Hanks SK
    Mol Cancer Res; 2005 Jun; 3(6):307-15. PubMed ID: 15972849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paracrine Fibroblast Growth Factor Initiates Oncogenic Synergy with Epithelial FGFR/Src Transformation in Prostate Tumor Progression.
    Li Q; Ingram L; Kim S; Beharry Z; Cooper JA; Cai H
    Neoplasia; 2018 Mar; 20(3):233-243. PubMed ID: 29444487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Src phosphorylates Cas on tyrosine 253 to promote migration of transformed cells.
    Goldberg GS; Alexander DB; Pellicena P; Zhang ZY; Tsuda H; Miller WT
    J Biol Chem; 2003 Nov; 278(47):46533-40. PubMed ID: 12972425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tyrosine phosphorylation of p120cbl in BCR/abl transformed hematopoietic cells mediates enhanced association with phosphatidylinositol 3-kinase.
    Jain SK; Langdon WY; Varticovski L
    Oncogene; 1997 May; 14(18):2217-28. PubMed ID: 9174058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The tyrosine kinase Abl is required for Src-transforming activity in mouse fibroblasts and human breast cancer cells.
    Sirvent A; Boureux A; Simon V; Leroy C; Roche S
    Oncogene; 2007 Nov; 26(52):7313-23. PubMed ID: 17533370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel Src/Abl tyrosine kinase inhibitor bosutinib suppresses neuroblastoma growth via inhibiting Src/Abl signaling.
    Bieerkehazhi S; Chen Z; Zhao Y; Yu Y; Zhang H; Vasudevan SA; Woodfield SE; Tao L; Yi JS; Muscal JA; Pang JC; Guan S; Zhang H; Nuchtern JG; Li H; Li H; Yang J
    Oncotarget; 2017 Jan; 8(1):1469-1480. PubMed ID: 27903968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of cell-cell interactions in the rapid stimulation of Cas tyrosine phosphorylation and Src kinase activity by transforming growth factor-beta 1.
    Kim JT; Joo CK
    J Biol Chem; 2002 Aug; 277(35):31938-48. PubMed ID: 12065577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrin-mediated cell adhesion promotes tyrosine phosphorylation of p130Cas, a Src homology 3-containing molecule having multiple Src homology 2-binding motifs.
    Nojima Y; Morino N; Mimura T; Hamasaki K; Furuya H; Sakai R; Sato T; Tachibana K; Morimoto C; Yazaki Y
    J Biol Chem; 1995 Jun; 270(25):15398-402. PubMed ID: 7541040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of v-src in embryonic neural retina alters cell adhesion, inhibits histogenesis, and prevents induction of glutamine synthetase.
    Vardimon L; Fox LE; Cohen-Kupiec R; Degenstein L; Moscona AA
    Mol Cell Biol; 1991 Oct; 11(10):5275-84. PubMed ID: 1681425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complexes of focal adhesion kinase (FAK) and Crk-associated substrate (p130(Cas)) are elevated in cytoskeleton-associated fractions following adhesion and Src transformation. Requirements for Src kinase activity and FAK proline-rich motifs.
    Polte TR; Hanks SK
    J Biol Chem; 1997 Feb; 272(9):5501-9. PubMed ID: 9038154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Src and Cas are essentially but differentially involved in angiotensin II-stimulated migration of vascular smooth muscle cells via extracellular signal-regulated kinase 1/2 and c-Jun NH2-terminal kinase activation.
    Kyaw M; Yoshizumi M; Tsuchiya K; Kagami S; Izawa Y; Fujita Y; Ali N; Kanematsu Y; Toida K; Ishimura K; Tamaki T
    Mol Pharmacol; 2004 Apr; 65(4):832-41. PubMed ID: 15044612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Second-generation Src/Abl inhibitor bosutinib effectively induces apoptosis in human esophageal squamous cell carcinoma (ESCC) cells via inhibiting Src/Abl signaling.
    Ha YNE; Dai Y; Wufuer D; Pidayi M; Anasihan G; Chen L
    Neoplasma; 2020 Jan; 67(1):54-60. PubMed ID: 31777258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.